PACIFIC BIOSCIENCES CALIF IN's ticker is PACB and the CUSIP is 69404D108. A total of 272 filers reported holding PACIFIC BIOSCIENCES CALIF IN in Q3 2023. The put-call ratio across all filers is 0.88 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $23,536,688 | -37.2% | 2,818,765 | +0.1% | 0.01% | -28.6% |
| Q2 2023 | $37,449,622 | +27.4% | 2,815,761 | +10.9% | 0.01% | +16.7% |
| Q1 2023 | $29,403,264 | +49.9% | 2,539,142 | +5.9% | 0.01% | +50.0% |
| Q4 2022 | $19,616,809 | +40.0% | 2,398,143 | -0.7% | 0.00% | +33.3% |
| Q3 2022 | $14,013,000 | +49.6% | 2,414,076 | +13.9% | 0.00% | +50.0% |
| Q2 2022 | $9,366,000 | -48.0% | 2,119,085 | +7.0% | 0.00% | -33.3% |
| Q1 2022 | $18,016,000 | -55.6% | 1,979,768 | -0.2% | 0.00% | -57.1% |
| Q4 2021 | $40,592,000 | -31.0% | 1,983,958 | -13.8% | 0.01% | -30.0% |
| Q3 2021 | $58,830,000 | -28.3% | 2,302,545 | -1.9% | 0.01% | -28.6% |
| Q2 2021 | $82,074,000 | +19.1% | 2,346,958 | +13.5% | 0.01% | +7.7% |
| Q1 2021 | $68,894,000 | +25.0% | 2,068,299 | -2.6% | 0.01% | +18.2% |
| Q4 2020 | $55,100,000 | +169.1% | 2,124,138 | +2.4% | 0.01% | +175.0% |
| Q3 2020 | $20,479,000 | +210.8% | 2,074,801 | +8.6% | 0.00% | +100.0% |
| Q2 2020 | $6,589,000 | +19.5% | 1,910,176 | +6.0% | 0.00% | 0.0% |
| Q1 2020 | $5,513,000 | -39.6% | 1,801,805 | +1.5% | 0.00% | 0.0% |
| Q4 2019 | $9,122,000 | -3.4% | 1,774,611 | -3.1% | 0.00% | 0.0% |
| Q3 2019 | $9,446,000 | -11.1% | 1,830,624 | +4.2% | 0.00% | -33.3% |
| Q2 2019 | $10,627,000 | -15.7% | 1,756,595 | +0.8% | 0.00% | 0.0% |
| Q1 2019 | $12,604,000 | +0.9% | 1,743,305 | +3.3% | 0.00% | -25.0% |
| Q4 2018 | $12,488,000 | +51.2% | 1,687,528 | +10.6% | 0.00% | +100.0% |
| Q3 2018 | $8,258,000 | +59.0% | 1,526,320 | +4.3% | 0.00% | +100.0% |
| Q2 2018 | $5,195,000 | +91.5% | 1,463,230 | +10.6% | 0.00% | 0.0% |
| Q1 2018 | $2,713,000 | -14.7% | 1,323,140 | +9.8% | 0.00% | 0.0% |
| Q4 2017 | $3,181,000 | -52.0% | 1,204,926 | -4.5% | 0.00% | -50.0% |
| Q3 2017 | $6,625,000 | +72.9% | 1,261,955 | +17.3% | 0.00% | +100.0% |
| Q2 2017 | $3,831,000 | -25.2% | 1,076,060 | +8.6% | 0.00% | 0.0% |
| Q1 2017 | $5,125,000 | +40.1% | 991,265 | +3.0% | 0.00% | 0.0% |
| Q4 2016 | $3,658,000 | -56.3% | 962,521 | +3.1% | 0.00% | -66.7% |
| Q3 2016 | $8,363,000 | +33.4% | 933,424 | +4.8% | 0.00% | +50.0% |
| Q2 2016 | $6,268,000 | -2.2% | 890,960 | +18.2% | 0.00% | 0.0% |
| Q1 2016 | $6,409,000 | -29.5% | 753,990 | +9.0% | 0.00% | -33.3% |
| Q4 2015 | $9,085,000 | +278.7% | 691,925 | +5.5% | 0.00% | +200.0% |
| Q3 2015 | $2,399,000 | -35.1% | 655,568 | +2.2% | 0.00% | 0.0% |
| Q2 2015 | $3,695,000 | +2.8% | 641,569 | +4.2% | 0.00% | 0.0% |
| Q1 2015 | $3,594,000 | -25.0% | 615,537 | +0.6% | 0.00% | 0.0% |
| Q4 2014 | $4,795,000 | +58.6% | 611,602 | -0.7% | 0.00% | 0.0% |
| Q3 2014 | $3,024,000 | -12.3% | 615,928 | +10.4% | 0.00% | 0.0% |
| Q2 2014 | $3,447,000 | +8.6% | 557,850 | -6.0% | 0.00% | 0.0% |
| Q1 2014 | $3,175,000 | -5.2% | 593,497 | -7.3% | 0.00% | 0.0% |
| Q4 2013 | $3,348,000 | -1.4% | 640,248 | +4.1% | 0.00% | 0.0% |
| Q3 2013 | $3,395,000 | +166.7% | 614,996 | +22.2% | 0.00% | – |
| Q2 2013 | $1,273,000 | – | 503,259 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 2,660,000 | $24,206,000 | 11.49% |
| Data Collective II GP, LLC | 164,249 | $1,495,000 | 5.44% |
| Decheng Capital Management III (Cayman), LLC | 1,463,872 | $13,321,000 | 4.08% |
| SB Management Ltd | 1,886,107 | $17,164,000 | 3.33% |
| Casdin Capital, LLC | 7,990,652 | $72,715,000 | 3.26% |
| ORACLE INVESTMENT MANAGEMENT INC | 1,225,395 | $11,151,000 | 2.20% |
| Jackson Square Partners, LLC | 22,542,589 | $205,137,000 | 2.04% |
| BOURNE LENT ASSET MANAGEMENT INC | 556,865 | $5,067,000 | 1.59% |
| ARK Investment Management | 27,259,521 | $248,062,000 | 1.04% |
| Nikko Asset Management Americas, Inc. | 14,021,205 | $127,873,000 | 0.94% |